SYRS (Syros Pharmaceuticals) Insider Ownership: 1.71 % (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SYRS Syros Pharmaceuticals Inc SYRS
12 GF Score
Price $0.01
View Full Analysis

What is Syros Pharmaceuticals Insider Ownership?

Syros Pharmaceuticals SYRS +2,900.00% 12 Insider Ownership is 1.71 % as of Sep. 16, 2026. GuruFocus rates SYRS with a GF Score™ of 12/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Syros Pharmaceuticals's insider ownership is 1.71%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Syros Pharmaceuticals's Institutional Ownership is 1.43%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Syros Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 91.91%.

Syros Pharmaceuticals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Syros Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syros Pharmaceuticals Insider Ownership Chart

Syros Pharmaceuticals Historical Data

The historical data trend for Syros Pharmaceuticals can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Insider Ownership 1.71 1.71 1.71 1.71 1.71 1.71 1.71 1.71 1.71 1.71
SYRS
12GF Score
Syros Pharmaceuticals Inc SYRS
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syros Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 1.71 % mean?
Syros Pharmaceuticals (SYRS) has a Insider Ownership of 1.71 % as of Sep. 16, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Syros Pharmaceuticals and its competitors.
Is Syros Pharmaceuticals' Insider Ownership too high?
Syros Pharmaceuticals' current Insider Ownership is 1.71 %. Overall, Syros Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Syros Pharmaceuticals' Insider Ownership compare to AFMDQ and BTAX?
Syros Pharmaceuticals' Insider Ownership of 1.71 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Syros Pharmaceuticals and its competitors. Syros Pharmaceuticals's current Insider Ownership is 1.71 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syros Pharmaceuticals stock overvalued right now?
Syros Pharmaceuticals (SYRS) has a current Insider Ownership of 1.71 %. The current Insider Ownership is 1.71 %. Syros Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Syros Pharmaceuticals (SYRS), the current Insider Ownership is 1.71 % as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syros Pharmaceuticals Business Description

Address 35 CambridgePark Drive, 4th Floor, Cambridge, MA, USA, 02140
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
12GF Score

Get the complete analysis for SYRS

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price